Roflumilast Attenuates Neuroinflammation and Cognitive Impairment in Intracerbroventricular-Streptozotocin Induced Rat Model of Sporadic Alzheimer’s Disease through Modulation of cAMP/BDNF Signaling Pathway

Abstract

Sporadic Alzheimer’s disease (SAD) is the most complex and multifactorial neurodegenerative disease characterized by progressive cognitive deficits and memory loss. Phosphodiesterase (PDE) inhibitors prevent the breakdown of cAMP in the brain, which is an important intracellular secondary messenger for learning and memory functions. Thus, the present study was designed to explore the therapeutic potential of PDE-4 inhibitor roflumilast (RFM) against intracerebroventricular-streptozotocin (ICV-STZ) induced SAD in rats. Subsequently, in vivo study was performed in which rats were infused intracerebroventricularly with two alternate doses of STZ (3 mg/kg bilaterally) proceeding with RFM (0.05 mg/kg orally) treatment for 15 days. Moreover, donepezil, an acetylcholinesterase inhibitor (5 mg/kg orally) was used as a standard drug. Consequently, we observed that RFM significantly improved the ICV-STZ impaired cognitive function in rats as assessed by novel object recognition and Morris Water Maze outcomes. RFM was found to remarkably mitigate the ICV-STZ triggered cholinergic deficits, neuroinflammation, oxidative stress, in rat hippocampus. Supporting these, histopathological analysis using Cresyl violet, and Congo red revealed that RFM attenuated neuronal changes, and Aβ deposition respectively in hippocampus of SAD rats. These outcomes present RFM as an efficient target for the treatment of SAD through activation of cAMP/BDNF signaling pathway.

Authors and Affiliations

Noorul Hasan, Abul Kalam Najmi, Suhel Parvez, Mohd Akhtar*

Keywords

Related Articles

A Novel Application of CuInS2/Zns Quantum Dot Nanoparticles: Dopamine Detection in Neuronal Synapses

Brain research is the most expanding interdisciplinary research that needs the state of the art technologies to offer advances and opportunities in order to better understanding of human brain while overcoming the chall...

Targeted Delivery of Quercetin-Loaded Magnetic Nanoparticles Decrease Seizure Activity and Ameliorate Kainate-Induced Memory Disturbances in the Animal Models of Epilepsy

Epilepsy is chronic neurological disease affecting roughly 1% of the human population. It is characterized by periodic repetitive seizures and associated cognitive impairments. Almost 30% of epileptic cases are refracto...

Modulation of Mitochondrial Voltage Dependent Anion Channel with Curcumin as a Neurodegenerative Therapy

The Voltage-Dependent Anion Channel (VDAC) plays a vital role in mitochondria-mediated transport of ions and metabolites. It is well established that mitochondria are a site for production of hydrogen peroxide (H2O2). D...

Role of miR-29b in Rotenone-Induced Mitochondrial Dysfunction in Neuronal Cells

Pesticides toxicity has become a global concern owing to its adverse pathophysiological effect and neurotoxic potential. Rotenone exposure represents a major public health concern that causes a variety of neurological...

Time Perception in Patients with Multiple Sclerosis

Time perception is how someone perceives time, which is not necessarily the same as what clocks show. It can be either how someone perceives time intervals between two consecutive events, recognizing a stimulus duration...

Download PDF file
  • EP ID EP701741
  • DOI -
  • Views 84
  • Downloads 0

How To Cite

Noorul Hasan, Abul Kalam Najmi, Suhel Parvez, Mohd Akhtar* (2021). Roflumilast Attenuates Neuroinflammation and Cognitive Impairment in Intracerbroventricular-Streptozotocin Induced Rat Model of Sporadic Alzheimer’s Disease through Modulation of cAMP/BDNF Signaling Pathway. The 2nd Annual Meeting of International Center for Neuroscience Research, 2(1), -. https://europub.co.uk/articles/-A-701741